Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses
- 4 November 2013
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (50) , E4904-E4912
Abstract
Pathogenic microorganisms and toxins have evolved a variety of mechanisms to gain access to the host-cell cytosol and thereby exert virulent effects upon the host. One common mechanism of cellular entry requires trafficking to an acidified endosome, which promotes translocation across the host membrane. To identify small-molecule inhibitors that block this process, a library of 30,000 small molecules was screened for inhibitors of anthrax lethal toxin. Here we report that 4-bromobenzaldehyde N-(2,6-dimethylphenyl)semicarbazone, the most active compound identified in the screen, inhibits intoxication by lethal toxin and blocks the entry of multiple other acid-dependent bacterial toxins and viruses into mammalian cells. This compound, which we named EGA, also delays lysosomal targeting and degradation of the EGF receptor, indicating that it targets host-membrane trafficking. In contrast, EGA does not block endosomal recycling of transferrin, retrograde trafficking of ricin, phagolysosomal trafficking, or phagosome permeabilization by Franciscella tularensis. Furthermore, EGA does not neutralize acidic organelles, demonstrating that its mechanism of action is distinct from pH-raising agents such as ammonium chloride and bafilomycin A1. EGA is a powerful tool for the study of membrane trafficking and represents a class of host-targeted compounds for therapeutic development to treat infectious disease. Significance Bacterial and viral infections are a significant public health burden. To corrupt normal host cellular functions, many bacterial toxins and all viruses must gain entry to host cells, a process that exploits the host’s own cellular machinery. In this study, we use high-throughput technologies to screen for chemical inhibitors of bacterial toxin and viral entry. We report the discovery of a small molecule that inhibits several viruses and bacterial toxins. In addition to the therapeutic potential, this compound represents a powerful probe for dissecting the mechanisms of mammalian membrane trafficking processes.Keywords
This publication has 67 references indexed in Scilit:
- Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule InhibitionCell, 2011
- Global gene disruption in human cells to assign genes to phenotypes by deep sequencingNature Biotechnology, 2011
- Novel approaches in anti-arenaviral drug developmentVirology, 2011
- Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screenToxicon, 2010
- Inhibition of Retrograde Transport Protects Mice from Lethal Ricin ChallengeCell, 2010
- Cellular and systemic effects of anthrax lethal toxin and edema toxinMolecular Aspects of Medicine, 2009
- The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric ComplexesJournal of Molecular Biology, 2009
- Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interestProceedings of the National Academy of Sciences, 2009
- Clathrin-Mediated Internalization Is Essential for Sustained EGFR Signaling but Dispensable for DegradationDevelopmental Cell, 2008
- Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replicationProceedings of the National Academy of Sciences, 2006